Read more Lipitor stories on Newserhttp://www.newser.com/taggrid/16283/lipitor.html2009 - Newseren-usNewser Feed GeneratorTue, 24 Nov 2009 11:19:26 CSThttp://www.newser.com/story/58990/pfizer-offers-free-lipitor-viagra-to-jobless.html?utm_source=syn&utm_medium=rss&utm_campaign=tagPfizer is unveiling a new program that will let people who have lost their jobs and health insurance keep taking some of its medications—including Lipitor and Viagra—for free for up to a year. The world’s biggest drugmaker will provide more than 70 of its prescription drugs free to...http://www.newser.com/story/58990/pfizer-offers-free-lipitor-viagra-to-jobless.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 14 May 2009 10:27:01 CDThttp://www.newser.com/story/50598/novartis-acquires-plavix-rival.html?utm_source=syn&utm_medium=rss&utm_campaign=tagNovartis AG will pay a San Francisco biopharmaceutical company $75 million—with the potential for an additional $500 million—for the worldwide rights to an experimental anticlotting drug the Swiss drug firm hopes will rival Plavix, reports the Wall Street Journal. Market leader Plavix rang up $8.22 billion in...http://www.newser.com/story/50598/novartis-acquires-plavix-rival.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 12 Feb 2009 8:22:53 CSThttp://www.newser.com/story/47797/pfizer-to-can-800-researchers.html?utm_source=syn&utm_medium=rss&utm_campaign=tagPfizer will eliminate the jobs of up to 800 researchers in 2009, starting today, the Wall Street Journal reports. The pharmaceutical giant is attempting to cut costs ahead of a $30 billion reduction in revenue expected in 2011 when its patent on the popular cholesterol drug Lipitor expires. But the...http://www.newser.com/story/47797/pfizer-to-can-800-researchers.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 13 Jan 2009 12:19:39 CSThttp://www.newser.com/story/46193/2008-hall-of-infamy-inductees.html?utm_source=syn&utm_medium=rss&utm_campaign=tagAs we look back at the great people who made their mark this year, let us not forget to document the schlubby, the sneaky, and the just plain criminal. Vanity Fair has done the legwork, rounding up a month-by-month rogue's gallery. Some highlights: January: Rudy Giuliani's Florida strategy was hapless...http://www.newser.com/story/46193/2008-hall-of-infamy-inductees.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 25 Dec 2008 20:21:45 CSThttp://www.newser.com/story/30361/deal-delays-generic-lipitor-until-2011.html?utm_source=syn&utm_medium=rss&utm_campaign=tagPfizer has struck a deal with an Indian generic drug maker to delay a cheaper version of Lipitor in the US until November 2011. The agreement limiting generic versions of the cholesterol-lowering drug will translate into billions more in profits for Pfizer, the New York Times reports. Lipitor, the world's...http://www.newser.com/story/30361/deal-delays-generic-lipitor-until-2011.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 18 Jun 2008 17:11:24 CDThttp://www.newser.com/story/26848/congress-to-probe-misleading-drug-ads.html?utm_source=syn&utm_medium=rss&utm_campaign=tagA congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug...http://www.newser.com/story/26848/congress-to-probe-misleading-drug-ads.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 08 May 2008 3:10:00 CDThttp://www.newser.com/story/20019/pfizer-pulls-lipitor-ads-after-probe.html?utm_source=syn&utm_medium=rss&utm_campaign=tagPfizer said today it will drop its ads for cholesterol drug Lipitor due to criticisms of the TV spots, the New York Times reports. US lawmakers recently probed whether the campaign had inflated the credentials of artificial heart developer Dr. Robert Jarvik. "The way in which we presented Dr. Jarvik...http://www.newser.com/story/20019/pfizer-pulls-lipitor-ads-after-probe.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 25 Feb 2008 19:55:00 CSThttp://www.newser.com/story/19599/prices-jump-for-top-drugs.html?utm_source=syn&utm_medium=rss&utm_campaign=tagDrug companies have slapped a series of huge price hikes on some prescription drugs ahead of drug patent expirations, the Wall Street Journal reports. GlaxoSmithKline has raised the price of antidepressant Wellbutrin 44.5%, while Sanofi-Aventis hiked Ambien's price 70%. Wholesale prices for the top 50 drugs increased an average...http://www.newser.com/story/19599/prices-jump-for-top-drugs.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 21 Feb 2008 4:45:00 CSThttp://www.newser.com/story/13425/big-pharma-faces-big-plunge.html?utm_source=syn&utm_medium=rss&utm_campaign=tagPatent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic...http://www.newser.com/story/13425/big-pharma-faces-big-plunge.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 06 Dec 2007 4:50:44 CST